BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The completion of the offering remains subject to market conditions.
The company intends to use the net proceeds for purchasing gold bullion, working capital, and general corporate purposes.
Offering Details
Shares of common stock (or pre-funded warrants) to be offered by the Company.
Underwriters
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Registration Statement
The offering is being made pursuant to a shelf registration statement on Form S-3.
- The offering aims to raise capital for specific purposes including investment in gold bullion and working capital.
- Clear Street and Needham & Company are playing vital roles in managing the offering process.
The public offering by BioSig Technologies Inc. marks a strategic move to raise funds for enhancing its operations and investment policies.